Health Outcomes Sciences

, offers a patented content enablement platform, ePRISM®, that translates scientific models into automated evidence-based decision support solutions. The company serves health and life science organizations. The company has partnerships with the American College of Cardiology for the delivery of NCDR® predictive risk models at the point of care, The American Heart Association, Centric Consulting, and Cerner among others. Health Outcome Sciences also has Six technology-related patents governing the use of mathematical models for projecting clinical outcomes. ePRISM® is accessible on virtually any type of computing device: desktop, laptop, tablet, iPad, smartphone or others, and can be fully integrated to an allied technology platform already established within the relevant clinical workflow, such as an EHR. As of 2021, the company staffs 22 employees. In 2019, Health Outcomes Sciences, Inc. The company’s platform ePRISM® provides instantaneous access to predictive models, at the point of care when clinical decisions are crucial. The platform arms physicians with predictive insights to have a better understanding of the specific risks of individual patients, thereby assisting them in making informed decisions. Predictive models established within ePRISM® can be used to access the patient risk of complications, mortality, disease, and readmissions among others, appropriate use, comparative effectiveness, functional assessment, quality of life, health status, treatment determination, survival duration, or probability of a defined outcome. Health Outcomes Sciences’ solutions allow healthcare organizations to personalize evidence for any care process. The company’s predictive content solutions are culled around domains such as cardiovascular, oncology, orthopedics, gastroenterology, and primary care as well as procedures, therapies, and modalities, systemic concerns, clinical settings, methods of care delivery such as home health, telehealth, and allied technologies. Predictive content solutions are designed for real-time automation processing with routine clinical workflows, allowing clinicians to gain personalized insights and are specialty agnostic, scalable at the enterprise level, and employ a cloud-hosted SaaS business model.

1. Series A

   Mar 5, 2014

   Amount

   $5M

   Investors

   Locked